With the right techniques and proper preparation, youll find the process simple and manageable
Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
Whats Inside AOD-9604 AOD-9604 stimulates lipid metabolism, and has the following benefits:
By injecting daily, youll at least ensure that you wont be getting worse
Choosing between AOD 9604 and tirzepatide is not really a close contest when you look purely at the clinical evidence for weight loss
Tailored Treatment: The dosage and form of B12 supplementation will always be tailored to your specific needs, the severity of your deficiency, and its root cause
